The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells.
R
R
Thijssen
J
J
Ter Burg
G G W
GG
van Bochove
M F M
MF
de Rooij
A
A
Kuil
M H
MH
Jansen
T W
TW
Kuijpers
J W
JW
Baars
A
A
Virone-Oddos
M
M
Spaargaren
C
C
Egile
M H J
MH
van Oers
E
E
Eldering
M J
MJ
Kersten
A P
AP
Kater